FDA now requires boxed warning on certain prescription sleeping medications

FDA now requires boxed warning on certain prescription sleeping medications

Bloomberg (4/30, Cortez) reports the Food and Drug Administration will now require a boxed warning on certain prescription sleeping drugs, including Ambien [zolpidem], Lunesta [eszopiclone], and Sonata (zaleplon), advising patients about the risk of serious side effects that can lead to death. The article explains that the agency “said it had found 66 examples of patients who took the drugs and engaged in dangerous activities such as sleepwalking or driving while not fully awake, including 20 deaths linked to carbon monoxide poisoning, drowning, fatal falls, hypothermia, car crashes and apparent suicide.”

Leave a Reply

Your email address will not be published. Required fields are marked *